APA (7th ed.) Citation

CM, F., L, P., M, A., & G, B. (2025). Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid: Successful Treatment with Dupilumab while Maintaining Immunotherapy. Case reports in oncology, 18(1), 1171. https://doi.org/10.1159/000547431

Chicago Style (17th ed.) Citation

CM, Florea, Parmentier L, Abdou M, and Berthod G. "Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid: Successful Treatment with Dupilumab While Maintaining Immunotherapy." Case Reports in Oncology 18, no. 1 (2025): 1171. https://doi.org/10.1159/000547431.

MLA (9th ed.) Citation

CM, Florea, et al. "Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid: Successful Treatment with Dupilumab While Maintaining Immunotherapy." Case Reports in Oncology, vol. 18, no. 1, 2025, p. 1171, https://doi.org/10.1159/000547431.